Low waist circumference prior to percutaneous coronary intervention predict the risk for end-stage renal disease: a nationwide Korean population based-cohort study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The obesity paradox has been known in end-stage renal disease (ESRD). However, the effect of body mass index (BMI) or waist circumference (WC) prior to percutaneous coronary intervention (PCI) on the development of ESRD is not clear. Methods: Using nationally representative data from the Korean National Health Insurance System, we enrolled 140,164 subjects without ESRD at enrolment who underwent PCI between 2010 and 2015, and were followed-up until 2017. Patients were stratified into five levels based on their baseline BMI and six levels based on their WC with 5-cm increments. BMI and WC were measured at least 2 years prior to PCI. The primary outcome was the development of ESRD. Results: During a median follow-up of 5.4 years, 2,082 (1.49%) participants developed ESRD. The underweight group (hazard ratio [HR], 1.331; 95% confidence interval [CI], 0.955 to 1.856) and low WC (< 80/< 75) (HR, 1.589; 95% CI, 1.379 to 1.831) showed the highest ESRD risk and the BMI 25 to 30 group showed the lowest ESRD risk (HR, 0.604; 95% CI, 0542 to 0.673) in all participants after adjusting for all covariates. In the subgroup analysis for diabetes mellitus (DM) duration, WC < 85/80 cm (men/women) increased ESRD risk in only the DM group (DM < 5 years and DM ≥ 5 years) compared to the reference group (85–90/80–85 of WC), but not the normal or impaired fasting glucose group. Conclusions: Low WC prior to PCI showed an increased ESRD risk in patients with DM undergoing PCI as compared to those without DM.
Abstract
Background/Aims: The obesity paradox has been known in end-stage renal disease (ESRD). However, the effect of body mass index (BMI) or waist circumference (WC) prior to percutaneous coronary intervention (PCI) on the development of ESRD is not clear. Methods: Using nationally representative data from the Korean National Health Insurance System, we enrolled 140,164 subjects without ESRD at enrolment who underwent PCI between 2010 and 2015, and were followed-up until 2017. Patients were stratified into five levels based on their baseline BMI and six levels based on their WC with 5-cm increments. BMI and WC were measured at least 2 years prior to PCI. The primary outcome was the development of ESRD. Results: During a median follow-up of 5.4 years, 2,082 (1.49%) participants developed ESRD. The underweight group (hazard ratio [HR], 1.331; 95% confidence interval [CI], 0.955 to 1.856) and low WC (< 80/< 75) (HR, 1.589; 95% CI, 1.379 to 1.831) showed the highest ESRD risk and the BMI 25 to 30 group showed the lowest ESRD risk (HR, 0.604; 95% CI, 0542 to 0.673) in all participants after adjusting for all covariates. In the subgroup analysis for diabetes mellitus (DM) duration, WC < 85/80 cm (men/women) increased ESRD risk in only the DM group (DM < 5 years and DM ≥ 5 years) compared to the reference group (85–90/80–85 of WC), but not the normal or impaired fasting glucose group. Conclusions: Low WC prior to PCI showed an increased ESRD risk in patients with DM undergoing PCI as compared to those without DM.
참고문헌 (30)
- Patterson RE, "A comprehensive examination of health conditions associated with obesity in older adults", Am J Prev Med, 27, pp.385~390 (2004)
- Yoon KH, "Epidemic obesity and type 2diabetes in Asia", Lancet, 368, pp.1681~1688 (2006)
- An R, "Global warming and obesity : a systematic review", Obes Rev, 19, pp.150~163 (2018)
- Ramachandran A, "Obesity in Asia : is it different from rest of the world", Diabetes Metab Res Rev, 28(Suppl 2), pp.47~51 (2012)
- Prospective Studies Collaboration, "Body-mass index and cause-specific mortality in 900000adults : collaborative analyses of 57 prospective studies", Lancet, 373, pp.1083~1096 (2009)
- Wang Y, "Association between obesity and kidney disease : a systematic review and meta-analysis", Kidney Int, 73, pp.19~33 (2008)
- Hsu CY, "Body mass index and risk for end-stage renal disease", Ann Intern Med, 144, pp.21~28 (2006)
- Fox CS, "Predictors of new-onset kidney disease in a community-based population", JAMA, 291, pp.844~850 (2004)
- Lin TY, "Obesity and risk of end-stage renal disease in patients with chronic kidney disease : a cohort study", Am J Clin Nutr, 108, pp.1145~1153 (2018)
- Yang HK, "Obesity, metabolic health, and mortality in adults : a nationwide population-based study in Korea", Sci Rep, 6, pp.30329~ (2016)
- 이용호, "Data Analytic Process of a Nationwide Population-Based Study Using National Health Information Database Established by National Health Insurance Service", Diabetes and Metabolism Journal, 40(1), pp.79~82 (2016), 대한당뇨병학회[DOI]
- The Asia-Pacific Perspective: Redefining Obesity and Its Treatment, "World Health Organization", Health Communications Australia, ~ (2000)
- Lee SY, "Appropriate waist circumference cutoffpoints for central obesity in Korean adults", Diabetes Res Clin Pract, 75, pp.72~80 (2007)
- Kim ES, "Impact of weight changes on the incidence of diabetes mellitus : a Korean nationwide cohort study", Sci Rep, 8, pp.3735~ (2018)
- Noh J, "Trends in the pervasiveness of type 2 diabetes, impaired fasting glucose and co-morbidities during an 8-year-follow-up of nationwide Korean population", Sci Rep, 7, pp.46656~ (2017)
- Koo DH, "The incremental risk of pancreatic cancer according to fasting glucose levels : nationwide population-based cohort study", J Clin Endocrinol Metab, 104, pp.4594~4599 (2019)
- Engin A, "The definition and prevalence of obesity and metabolic syndrome", Adv Exp Med Biol, 960, pp.1~17 (2017)
- Ahmadi SF, "Association of body mass index with clinical outcomes in non-dialysis-dependent chronic kidney disease : a systematic review and meta-analysis", Cardiorenal Med, 6, pp.37~49 (2015)
- Lu JL, "Association of body mass index with outcomes in patients with CKD", J Am Soc Nephrol, 25, pp.2088~2096 (2014)
- Dhoot J, "Effect of morbid obesity on in-hospital mortality and coronary revascularization outcomes after acute myocardial infarction in the United States", Am J Cardiol, 111, pp.1104~1110 (2013)
- Ellis SG, "Low-normal or excessive body mass index : newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention", Am J Cardiol, 78, pp.642~646 (1996)
- Gruberg L, "The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention : the obesity paradox?", J Am Coll Cardiol, 39, pp.578~584 (2002)
- Oreopoulos A, "Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis", Obesity(Silver Spring), 16, pp.442~450 (2008)
- Kim YH, "Waist circumference and allcause mortality independent of body mass index in Korean population from the National Health Insurance health checkup 2009-2015", J Clin Med, 8, pp.72~ (2019)
- Kittiskulnam P, "The obesity paradox : a further consideration in dialysis patients", Semin Dial, 32, pp.485~489 (2019)
- Delgado C, "Associations of body mass index and body fat with markers of inflammation and nutrition among patients receiving hemodialysis", Am J Kidney Dis, 70, pp.817~825 (2017)
- Postorino M, "Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease", J Am Coll Cardiol, 53, pp.1265~1272 (2009)
- Postorino M, "Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients", Kidney Int, 79, pp.765~772 (2011)
- Coutinho T, "Central obesity and survival in subjects with coronary artery disease : a systematic review of the literature and collaborative analysis with individual subject data", J Am Coll Cardiol, 57, pp.1877~1886 (2011)
- Lavie CJ, "Body composition and survival in stable coronary heart disease : impact of lean mass index and body fat in the"obesity paradox"", J Am Coll Cardiol, 60, pp.1374~1380 (2012)